Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DNA Methylation Testing for the Screening of Uterine Cervical Lesion: A Multicenter, Prospective Cohort Study

NCT04646954 is registered in ClinicalTrials.gov with Lei Li as lead sponsor.

NCT NCT04646954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04646954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DNA Methylation Testing for the Screening of Uterine Cervical Lesion: A Multicenter, Prospective Cohort Study
Lead sponsor
Lei Li
Phase
Phase 3
Overall status
Unknown status
Start date
November 26, 2020
Completion date
November 26, 2022
Enrollment
12,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, cervical intraepithelial neoplasia, cytology, dna methylation, high-risk human papillomavirus